Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
novel transcript, antisense to Chromosome 19 open reading frame 66
- Molecular classification
- Non-coding RNA
01
Overview
The "novel transcript, antisense to Chromosome 19 open reading frame 66" (ENSG00000267387) is an uncharacterized non-coding RNA located on the antisense strand of the C19orf66 gene region. Unlike the well-studied sense strand product C19orf66 (also known as SHFL, RyDEN, IRAV), which encodes a protein with broad-spectrum antiviral activity, this antisense transcript has no direct evidence of protein-coding potential, biological activity, or disease association in currently available research. Its function may be related to cis-regulatory effects on C19orf66 expression, as is often seen with antisense RNAs, but such a role has not been experimentally validated for this specific transcript. This entry is not considered a canonical therapeutic target, and its biological significance remains unknown[4][9].
- Other names
- antisense transcript to C19orf66antisense RNA (to SHFL, RyDEN, IRAV, C19orf66)
02
Biological functions
Potential regulation of C19orf66 expression via antisense interaction (speculative, common for antisense transcripts)Other (no specific biological activity established in literature)
03
Disease associations
Other (no established disease association)
Beyond the preview
Go deeper on novel transcript, antisense to Chromosome 19 open reading frame 66.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on novel transcript, antisense to Chromosome 19 open reading frame 66.